Dr. Rishabh Jain
@ujjaiyanieyesospitle • Joined January 28, 2011
At a glance
Subscribers
Last 28 days10.9K
Views
Last 28 days1.72M
Videos
Last 28 days2.07K
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
831
Total views ÷ total videos
Views per subscriber
158×
Total views ÷ subscribers
Subs per video
5
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $1.20K – $3.45K
Daily avg.: $0 – $0
Weekly avg.: $0 – $1
Last 28 days: $1 – $4
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Dr. Rishabh Jain
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 1, 2026 Jun 1 Mon | 10.9K -- | 1.72M +334 | 2.07K -- |
May 25, 2026 May 25 Mon | 10.9K -- | 1.72M +443 | 2.07K -- |
May 18, 2026 May 18 Mon | 10.9K -- | 1.72M +236 | 2.07K -- |
May 11, 2026 May 11 Mon | 10.9K -- | 1.72M +707 | 2.07K -- |
May 9, 2026 May 9 Sat | 10.9K -- | 1.72M +1.07K | 2.07K -- |
Apr 21, 2026 Apr 21 Tue | 10.9K -- | 1.72M -- | 2.07K -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
May 9, 2026 | 0 | -- |
May 11, 2026 | 0 | -- |
May 18, 2026 | 0 | -- |
May 25, 2026 | 0 | -- |
Jun 1, 2026 | 0 | -- |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
May 9, 2026 | 1.07K | +1.07K |
May 11, 2026 | 707 | -364 |
May 18, 2026 | 236 | -471 |
May 25, 2026 | 443 | +207 |
Jun 1, 2026 | 334 | -109 |
About
TREATMENT AND CURE FOR COLOR BLINDNESS ONLY IN INDIA CONT. Dr. RISHAB H JAIN FOR ANY TYPE EYES PROBLEM LIKE RP CB MD VISION CAN IMPROVE 100 %-Dr RISHABH JAIN +919425092329 UJJAIN [ M P ] 1.TREATMENT OF RETINITIS PIGMENTOSA AND CURE FOR RETINITIS PIGMENTOSA 2..TREATMENT OF COLOR BLINDNESS . 3. AMB4LYOPIA ( PARALYSIS…
- Handle
- @ujjaiyanieyesospitle
- Joined
- January 28, 2011
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.